{"sourcedb":"DevicePMAs@therightstef","sourceid":"P060008_S008","text":"Approval to expand the product matrix to include the 2.25 mm taxusliberte paclitaxel-eluting coronary stent system. this device size will be marketed under thetrade name taxus liberte atom paclitaxel-eluting coronary stent system (monorail and over-the-wire delivery systems), and is indicated for improving luminal diameter for thetreatment of de novo lesions in native coronary arteries \u003E =2.25 mm to \u003C= 4.00 mm in diameter inlesions \u003C= 28 mm in length.","project":"consensus_PMA_Age_Indications"}